ArticleCureus2026
Recurrent Pyelonephritis in Quadriplegia: Rethinking Oral Cefdinir in the Presence of Nephrolithiasis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with cerebral palsy who develop functional quadriplegia are at an increased risk for recurrent urinary tract infections and kidney stones. Impaired bladder emptying, chronic constipation, and reduced physical mobility collectively promote urinary stasis and bacterial growth. Despite the frequency of these complications, there is little guidance in the currently available literature on how to select appropriate empiric oral antibiotics for pyelonephritis in this patient population, especially when renal stones are also present. This case highlights the importance of careful antibiotic selection in patients with neurogenic bladder and nephrolithiasis. Oral cefdinir demonstrates limited renal tissue penetration, which may reduce its effectiveness in treating complicated urinary tract infections. In contrast, fluoroquinolones provide superior penetration into renal tissue, making them a more suitable option in specific scenarios. Choosing antibiotics that align with the patient's clinical presentation and pharmacological requirements can significantly reduce recurrence and improve outcomes in quadriplegic patients with recurrent kidney stones. This case report demonstrates that selecting antibiotics with sufficient renal tissue penetration can improve outcomes in complicated pyelonephritis, with symptom resolution after antibiotic change.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.